Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 65

1.

TFCP2 activates beta-catenin/TCF signaling in the progression of pancreatic cancer.

Yuedi D, Yuankun C, Jiaying Z, Han L, Yueqi W, Houbao L, Dexiang Z.

Oncotarget. 2017 Jul 31;8(41):70538-70549. doi: 10.18632/oncotarget.19741. eCollection 2017 Sep 19.

2.

TRIM24 promotes the aggression of gastric cancer via the Wnt/β-catenin signaling pathway.

Fang Z, Deng J, Zhang L, Xiang X, Yu F, Chen J, Feng M, Xiong J.

Oncol Lett. 2017 Mar;13(3):1797-1806. doi: 10.3892/ol.2017.5604. Epub 2017 Jan 17.

3.

YEATS4 promotes the tumorigenesis of pancreatic cancer by activating beta-catenin/TCF signaling.

Jixiang C, Shengchun D, Jianguo Q, Zhengfa M, Xin F, Xuqing W, Jianxin Z, Lei C.

Oncotarget. 2017 Apr 11;8(15):25200-25210. doi: 10.18632/oncotarget.15633.

4.

TRIM14 regulates cell proliferation and invasion in osteosarcoma via promotion of the AKT signaling pathway.

Xu G, Guo Y, Xu D, Wang Y, Shen Y, Wang F, Lv Y, Song F, Jiang D, Zhang Y, Lou Y, Meng Y, Yang Y, Kang Y.

Sci Rep. 2017 Feb 16;7:42411. doi: 10.1038/srep42411.

5.

SRI36160 is a specific inhibitor of Wnt/β-catenin signaling in human pancreatic and colorectal cancer cells.

Li Y, Oliver PG, Lu W, Pathak V, Sridharan S, Augelli-Szafran CE, Buchsbaum DJ, Suto MJ.

Cancer Lett. 2017 Mar 28;389:41-48. doi: 10.1016/j.canlet.2016.12.030. Epub 2016 Dec 30.

PMID:
28043913
6.

Activation of WNT/β-Catenin Signaling Enhances Pancreatic Cancer Development and the Malignant Potential Via Up-regulation of Cyr61.

Sano M, Driscoll DR, DeJesus-Monge WE, Quattrochi B, Appleman VA, Ou J, Zhu LJ, Yoshida N, Yamazaki S, Takayama T, Sugitani M, Nemoto N, Klimstra DS, Lewis BC.

Neoplasia. 2016 Dec;18(12):785-794. doi: 10.1016/j.neo.2016.11.004. Epub 2016 Nov 25.

7.

The Breast Cancer Tumor Suppressor TRIM29 Is Expressed via ATM-dependent Signaling in Response to Hypoxia.

Dükel M, Streitfeld WS, Tang TC, Backman LR, Ai L, May WS, Brown KD.

J Biol Chem. 2016 Oct 7;291(41):21541-21552. Epub 2016 Aug 17.

8.

Identification of nasopharyngeal carcinoma metastasis-related biomarkers by iTRAQ combined with 2D-LC-MS/MS.

Chen Z, Long L, Wang K, Cui F, Zhu L, Tao Y, Wu Q, Xiang M, Liang Y, Qiu S, Xiao Z, Yi B.

Oncotarget. 2016 Jun 7;7(23):34022-37. doi: 10.18632/oncotarget.9067.

9.

Upregulated TRIM29 promotes proliferation and metastasis of nasopharyngeal carcinoma via PTEN/AKT/mTOR signal pathway.

Zhou XM, Sun R, Luo DH, Sun J, Zhang MY, Wang MH, Yang Y, Wang HY, Mai SJ.

Oncotarget. 2016 Mar 22;7(12):13634-50. doi: 10.18632/oncotarget.7215.

10.

Upregulation of the expression of Wnt5a promotes the proliferation of pancreatic cancer cells in vitro and in a nude mouse model.

Bo H, Gao L, Chen Y, Zhang J, Zhu M.

Mol Med Rep. 2016 Feb;13(2):1163-71. doi: 10.3892/mmr.2015.4642. Epub 2015 Dec 4.

11.

Chemopreventive effect of resveratrol and apocynin on pancreatic carcinogenesis via modulation of nuclear phosphorylated GSK3β and ERK1/2.

Kato A, Naiki-Ito A, Nakazawa T, Hayashi K, Naitoh I, Miyabe K, Shimizu S, Kondo H, Nishi Y, Yoshida M, Umemura S, Hori Y, Mori T, Tsutsumi M, Kuno T, Suzuki S, Kato H, Ohara H, Joh T, Takahashi S.

Oncotarget. 2015 Dec 15;6(40):42963-75. doi: 10.18632/oncotarget.5981.

12.

The canonical Wnt pathway regulates the metastasis-promoting mucin MUC4 in pancreatic ductal adenocarcinoma.

Pai P, Rachagani S, Lakshmanan I, Macha MA, Sheinin Y, Smith LM, Ponnusamy MP, Batra SK.

Mol Oncol. 2016 Feb;10(2):224-39. doi: 10.1016/j.molonc.2015.10.005. Epub 2015 Oct 19.

13.

ATDC/TRIM29 Drives Invasive Bladder Cancer Formation through miRNA-Mediated and Epigenetic Mechanisms.

Palmbos PL, Wang L, Yang H, Wang Y, Leflein J, Ahmet ML, Wilkinson JE, Kumar-Sinha C, Ney GM, Tomlins SA, Daignault S, Kunju LP, Wu XR, Lotan Y, Liebert M, Ljungman ME, Simeone DM.

Cancer Res. 2015 Dec 1;75(23):5155-66. doi: 10.1158/0008-5472.CAN-15-0603. Epub 2015 Oct 15.

14.

ATDC (Ataxia Telangiectasia Group D Complementing) Promotes Radioresistance through an Interaction with the RNF8 Ubiquitin Ligase.

Yang H, Palmbos PL, Wang L, Kim EH, Ney GM, Liu C, Prasad J, Misek DE, Yu X, Ljungman M, Simeone DM.

J Biol Chem. 2015 Nov 6;290(45):27146-57. doi: 10.1074/jbc.M115.665489. Epub 2015 Sep 17.

15.
16.

Glycogen Synthase Kinase 3 Beta Predicts Survival in Resected Adenocarcinoma of the Pancreas.

Ben-Josef E, George A, Regine WF, Abrams R, Morgan M, Thomas D, Schaefer PL, DiPetrillo TA, Fromm M, Small W Jr, Narayan S, Winter K, Griffith KA, Guha C, Williams TM.

Clin Cancer Res. 2015 Dec 15;21(24):5612-8. doi: 10.1158/1078-0432.CCR-15-0789. Epub 2015 Aug 3.

17.

TRIM29 functions as an oncogene in gastric cancer and is regulated by miR-185.

Qiu F, Xiong JP, Deng J, Xiang XJ.

Int J Clin Exp Pathol. 2015 May 1;8(5):5053-61. eCollection 2015.

18.

Inhibition of β-catenin signaling suppresses pancreatic tumor growth by disrupting nuclear β-catenin/TCF-1 complex: critical role of STAT-3.

Pramanik KC, Fofaria NM, Gupta P, Ranjan A, Kim SH, Srivastava SK.

Oncotarget. 2015 May 10;6(13):11561-74.

19.

Downregulation of miR-432 activates Wnt/β-catenin signaling and promotes human hepatocellular carcinoma proliferation.

Jiang N, Chen WJ, Zhang JW, Xu C, Zeng XC, Zhang T, Li Y, Wang GY.

Oncotarget. 2015 Apr 10;6(10):7866-79.

20.

The heparan sulfate mimetic PG545 interferes with Wnt/β-catenin signaling and significantly suppresses pancreatic tumorigenesis alone and in combination with gemcitabine.

Jung DB, Yun M, Kim EO, Kim J, Kim B, Jung JH, Wang E, Mukhopadhyay D, Hammond E, Dredge K, Shridhar V, Kim SH.

Oncotarget. 2015 Mar 10;6(7):4992-5004.

Supplemental Content

Support Center